{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:14:28Z","timestamp":1790518468984,"version":"4.1.0"},"reference-count":190,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bbalip.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T22:34:52Z","timestamp":1533681292000},"page":"1257-1273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A critical appraisal of the measurement of serum \u2018cholesterol efflux capacity\u2019 and its use as surrogate marker of risk of cardiovascular disease"],"prefix":"10.1016","volume":"1863","author":[{"given":"Malcolm","family":"Anastasius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Luquain-Costaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Kockx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Jessup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Kritharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2018.08.002_bb0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/pr.58.3.1","article-title":"Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis","volume":"58","author":"Kontush","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2016.01.005","article-title":"New therapeutic approaches to the treatment of dyslipidemia","volume":"23","author":"Rader","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0025","series-title":"Handbook of Experimental Pharmacology","first-page":"3","article-title":"Structure of HDL: particle subclasses and molecular components","author":"Kontush","year":"2014"},{"issue":"Suppl","key":"10.1016\/j.bbalip.2018.08.002_bb0030","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1194\/jlr.R800034-JLR200","article-title":"The metabolism and anti-atherogenic properties of HDL","volume":"50","author":"Rye","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biochi.2015.06.022","article-title":"Can phosphatidylserine enhance atheroprotective activities of high-density lipoprotein?","volume":"120","author":"Darabi","year":"2016","journal-title":"Biochimie"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0040","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.M059089","article-title":"Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity","volume":"56","author":"Vaisar","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0045","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jacc.2015.09.012","article-title":"Cholesterol efflux capacity as a therapeutic target: rationale and clinical implications","volume":"66","author":"Rohatgi","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jcmm.12689","article-title":"Macrophage-mediated cholesterol handling in atherosclerosis","volume":"20","author":"Chistiakov","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MOL.0b013e32834adadb","article-title":"Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles","volume":"22","author":"Kruth","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0060","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-319-09665-0_4","article-title":"Cholesterol efflux and reverse cholesterol transport","volume":"224","author":"Favari","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-4157(87)90013-X","article-title":"Mechanisms and consequences of cellular cholesterol exchange and transfer","volume":"906","author":"Phillips","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0075","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1016\/S0021-9258(18)34593-9","article-title":"Mechanism of cholesterol efflux from cells. Effects of acceptor structure and concentration","volume":"257","author":"Rothblat","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.plipres.2008.03.001","article-title":"Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol","volume":"47","author":"Lange","year":"2008","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0085","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1074\/jbc.271.4.2023","article-title":"Regulation of cellular cholesterol efflux by lecithin:cholesterol acyltransferase reaction through nonspecific lipid exchange","volume":"271","author":"Czarnecka","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.atherosclerosis.2017.01.034","article-title":"Atherosclerosis","volume":"258","author":"Hoekstra","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tem.2017.02.001","article-title":"SR-BI: a multifunctional receptor in cholesterol homeostasis and atherosclerosis","volume":"28","author":"Linton","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0100","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0105","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.1074\/jbc.270.27.16221","article-title":"The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids","volume":"270","author":"Rigotti","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0110","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1074\/jbc.272.28.17551","article-title":"Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes","volume":"272","author":"Murao","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0115","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0022-2275(20)37413-7","article-title":"Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake","volume":"38","author":"Xu","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0120","doi-asserted-by":"crossref","first-page":"31002","DOI":"10.1074\/jbc.273.47.31002","article-title":"Scavenger receptor, class B, type I-dependent stimulation of cholesterol esterification by high density lipoproteins, low density lipoproteins, and nonlipoprotein cholesterol","volume":"273","author":"Stangl","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0125","doi-asserted-by":"crossref","first-page":"20982","DOI":"10.1074\/jbc.272.34.20982","article-title":"Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux","volume":"272","author":"Ji","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0130","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1074\/jbc.273.10.5599","article-title":"Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors","volume":"273","author":"Jian","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/bi991666c","article-title":"Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution","volume":"39","author":"Kellner-Weibel","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0140","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-2275(20)32462-7","article-title":"Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface","volume":"40","author":"de la Llera-Moya","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0145","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1074\/jbc.M311718200","article-title":"Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure","volume":"279","author":"Thuahnai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0150","doi-asserted-by":"crossref","first-page":"32692","DOI":"10.1074\/jbc.274.46.32692","article-title":"Transport of lipids from high and low density lipoproteins via scavenger receptor-BI","volume":"274","author":"Stangl","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0155","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1194\/jlr.M300461-JLR200","article-title":"Sterol regulation of scavenger receptor class B type I in macrophages","volume":"45","author":"Yu","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2011.03.017","article-title":"Scavenger receptor SR-BI in macrophage lipid metabolism","volume":"217","author":"Ji","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0165","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/ATVBAHA.109.194548","article-title":"Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent","volume":"29","author":"Larrede","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/01.RES.85.1.108","article-title":"Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions","volume":"85","author":"Hirano","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0175","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1161\/01.CIR.101.20.2411","article-title":"CLA-1\/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors","volume":"101","author":"Chinetti","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0180","doi-asserted-by":"crossref","first-page":"34414","DOI":"10.1074\/jbc.M113.508812","article-title":"Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants","volume":"288","author":"Quazi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0185","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.R082313","article-title":"Is ABCA1 a lipid transfer protein?","author":"Phillips","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0006-291X(02)02745-6","article-title":"The C-terminal domain of apolipoprotein A-I is involved in ABCA1-driven phospholipid and cholesterol efflux","volume":"299","author":"Favari","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0195","doi-asserted-by":"crossref","first-page":"39477","DOI":"10.1074\/jbc.M207005200","article-title":"The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1","volume":"277","author":"Panagotopulos","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0200","doi-asserted-by":"crossref","first-page":"36091","DOI":"10.1074\/jbc.M602247200","article-title":"ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions","volume":"281","author":"Landry","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0205","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1194\/jlr.M300078-JLR200","article-title":"ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions","volume":"44","author":"Vaughan","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0210","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/ATVBAHA.107.145789","article-title":"ABCA1-induced cell surface binding sites for ApoA-I","volume":"27","author":"Vedhachalam","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0215","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1194\/jlr.M700206-JLR200","article-title":"Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis","volume":"48","author":"Hajj Hassan","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0220","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M704590200","article-title":"Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles","volume":"282","author":"Vedhachalam","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0225","doi-asserted-by":"crossref","first-page":"17852","DOI":"10.1074\/jbc.271.30.17852","article-title":"Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol","volume":"271","author":"Gelissen","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0230","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.ATV.0000104029.74961.f5","article-title":"Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I","volume":"24","author":"Rye","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0235","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1161\/ATVBAHA.107.142455","article-title":"Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1","volume":"27","author":"Mulya","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0240","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1021\/bi901564g","article-title":"Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1","volume":"48","author":"Favari","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0245","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.116.305485","article-title":"HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export","volume":"116","author":"Du","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0250","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1194\/jlr.M300257-JLR200","article-title":"Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL","volume":"45","author":"Okuhira","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0255","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","article-title":"Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor\/retinoid X receptor","volume":"275","author":"Costet","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0260","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.1073\/pnas.200367697","article-title":"Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha","volume":"97","author":"Venkateswaran","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0265","doi-asserted-by":"crossref","first-page":"34508","DOI":"10.1074\/jbc.M006738200","article-title":"ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages","volume":"275","author":"Oram","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0270","doi-asserted-by":"crossref","first-page":"28634","DOI":"10.1074\/jbc.M003407200","article-title":"The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines","volume":"275","author":"Bortnick","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0275","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.ATV.0000201042.00725.84","article-title":"Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3\/4 elements","volume":"26","author":"Le Goff","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0280","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1194\/jlr.M400482-JLR200","article-title":"Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux","volume":"46","author":"Kiss","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0285","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1074\/jbc.M113.515890","article-title":"Cellular cholesterol regulates ubiquitination and degradation of the cholesterol export proteins ABCA1 and ABCG1","volume":"289","author":"Hsieh","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0290","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbalip.2011.07.011","article-title":"Dancing with the sterols: critical roles for ABCG1, ABCA1, miRNAs, and nuclear and cell surface receptors in controlling cellular sterol homeostasis","volume":"1821","author":"Tarling","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091892","article-title":"Critical role of the human ATP-binding cassette G1 transporter in cardiometabolic diseases","volume":"18","author":"Hardy","year":"2017","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0300","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.0000200082.58536.e1","article-title":"ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I","volume":"26","author":"Gelissen","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0305","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1194\/jlr.M500546-JLR200","article-title":"Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1","volume":"47","author":"Kobayashi","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0310","doi-asserted-by":"crossref","first-page":"30150","DOI":"10.1074\/jbc.M505368200","article-title":"ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins","volume":"280","author":"Vaughan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0315","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.febslet.2007.03.038","article-title":"Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol","volume":"581","author":"Engel","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0320","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.1073\/pnas.0704602104","article-title":"High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1","volume":"104","author":"Terasaka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0325","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1096\/fj.07-9944com","article-title":"ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain","volume":"22","author":"Wang","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0330","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/ATVBAHA.110.205617","article-title":"Impaired development of atherosclerosis in Abcg1\u2212\/\u2212 Apoe\u2212\/\u2212 mice: identification of specific oxysterols that both accumulate in Abcg1\u2212\/\u2212 Apoe\u2212\/\u2212 tissues and induce apoptosis","volume":"30","author":"Tarling","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0335","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.bbalip.2014.10.003","article-title":"ABCG1 is involved in vitamin E efflux","volume":"1841","author":"Olivier","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0340","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/ATVBAHA.115.306592","article-title":"Identification of an amino acid residue critical for plasma membrane localization of ATP-binding cassette transporter G1\u2014brief report","volume":"36","author":"Gu","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0345","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1172\/JCI41280","article-title":"An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells","volume":"120","author":"Sturek","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0350","doi-asserted-by":"crossref","first-page":"19719","DOI":"10.1073\/pnas.1113021108","article-title":"ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter","volume":"108","author":"Tarling","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0355","doi-asserted-by":"crossref","first-page":"42025","DOI":"10.1038\/srep42025","article-title":"The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments","volume":"7","author":"Pandzic","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1194\/jlr.M700364-JLR200","article-title":"ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2","volume":"49","author":"Tarr","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0365","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1194\/jlr.M800362-JLR200","article-title":"Effects of acceptor composition and mechanism of ABCG1-mediated cellular free cholesterol efflux","volume":"50","author":"Sankaranarayanan","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0370","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0375","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cmet.2005.01.002","article-title":"ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation","volume":"1","author":"Kennedy","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1194\/jlr.M900250-JLR200","article-title":"Differential expression and function of ABCG1 and ABCG4 during development and aging","volume":"51","author":"Bojanic","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0385","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1073\/pnas.97.2.817","article-title":"ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport","volume":"97","author":"Klucken","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0390","doi-asserted-by":"crossref","first-page":"14700","DOI":"10.1074\/jbc.275.19.14700","article-title":"Human white\/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols","volume":"275","author":"Venkateswaran","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0395","doi-asserted-by":"crossref","first-page":"39438","DOI":"10.1074\/jbc.M105863200","article-title":"Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein","volume":"276","author":"Kennedy","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0400","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1194\/jlr.M500080-JLR200","article-title":"The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver","volume":"46","author":"Sabol","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0405","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1194\/jlr.M700274-JLR200","article-title":"The roles of different pathways in the release of cholesterol from macrophages","volume":"48","author":"Adorni","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0410","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1161\/ATVBAHA.113.301719","article-title":"ATP-binding cassette transporter A1 in lipoprotein metabolism and atherosclerosis: a new piece of the complex puzzle","volume":"33","author":"Van Eck","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0415","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1172\/JCI32057","article-title":"Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0420","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/CIRCRESAHA.110.226282","article-title":"Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet","volume":"107","author":"Zhao","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0425","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCRESAHA.107.161711","article-title":"Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1","volume":"102","author":"Out","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0430","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsbmb.2009.04.008","article-title":"Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17beta-estradiol fatty acyl esters","volume":"116","author":"Badeau","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0435","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-6875-6_21","article-title":"Measurement of macrophage-specific in vivo reverse cholesterol transport in mice","volume":"1583","author":"Kockx","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0440","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.0000086981.09834.E0","article-title":"Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0445","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/ATVBAHA.107.146068","article-title":"In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0450","doi-asserted-by":"crossref","first-page":"12610","DOI":"10.1073\/pnas.94.23.12610","article-title":"A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism","volume":"94","author":"Rigotti","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0455","doi-asserted-by":"crossref","first-page":"23699","DOI":"10.1074\/jbc.M211233200","article-title":"Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver","volume":"278","author":"Van Eck","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0460","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1172\/JCI26893","article-title":"Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues","volume":"116","author":"Huby","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0465","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/01.ATV.0000083343.19940.A0","article-title":"Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells","volume":"23","author":"Covey","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0470","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0002-9440(10)63341-X","article-title":"Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development","volume":"165","author":"Van Eck","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0475","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.97.8.4245","article-title":"High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1","volume":"97","author":"McNeish","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0480","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9440(10)64614-7","article-title":"Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency","volume":"157","author":"Christiansen-Weber","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0485","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1073\/pnas.092327399","article-title":"Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues","volume":"99","author":"Van Eck","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0490","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.ATV.0000054661.21499.FB","article-title":"ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation","volume":"23","author":"Aiello","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0495","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.ATV.0000208364.22732.16","article-title":"Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice","volume":"26","author":"Van Eck","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0500","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.ATV.0000257136.24308.0c","article-title":"Total body ABCG1 expression protects against early atherosclerotic lesion development in mice","volume":"27","author":"Out","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0505","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1161\/01.ATV.0000237629.29842.4c","article-title":"Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice","volume":"26","author":"Out","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0510","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/01.ATV.0000240051.22944.dc","article-title":"Impaired development of atherosclerosis in hyperlipidemic Ldlr\u2212\/\u2212 and ApoE\u2212\/\u2212 mice transplanted with Abcg1\u2212\/\u2212 bone marrow","volume":"26","author":"Bald\u00e1n","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0515","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.ATV.0000242275.92915.43","article-title":"Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1\u2212\/\u2212 bone marrow","volume":"26","author":"Ranalletta","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0520","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.atherosclerosis.2009.01.017","article-title":"Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development","volume":"205","author":"Lammers","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0525","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/ATVBAHA.107.156935","article-title":"Combined deletion of macrophage ABCA1 and ABCG1 leads to massive lipid accumulation in tissue macrophages and distinct atherosclerosis at relatively low plasma cholesterol levels","volume":"28","author":"Out","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0530","first-page":"3900","article-title":"Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice","volume":"117","author":"Yvan-Charvet","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0535","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"114","author":"Westerterp","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0540","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.RES.0000250171.54048.5c","article-title":"ATP-binding cassette cholesterol transporters and cardiovascular disease","volume":"99","author":"Oram","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0545","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1388-1981(00)00157-8","article-title":"Tangier disease and ABCA1","volume":"1529","author":"Oram","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0550","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.0954-6820.2003.01256.x","article-title":"HDL deficiency and atherosclerosis: lessons from Tangier disease","volume":"255","author":"Hovingh","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0555","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-93-2-261","article-title":"Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)","volume":"93","author":"Schaefer","year":"1980","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0560","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0565","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5551\/jat.E380","article-title":"Genotypic effect of ABCG1 gene promoter \u2212257T>G polymorphism on coronary artery disease severity in Japanese men","volume":"16","author":"Furuyama","year":"2009","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0570","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/ATVBAHA.111.234872","article-title":"Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease","volume":"32","author":"Schou","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032166","article-title":"Monocyte gene expression signature of patients with early onset coronary artery disease","volume":"7","author":"Sivapalaratnam","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0580","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.ATV.14.7.1056","article-title":"A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer","volume":"14","author":"de la Llera Moya","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0585","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.ATV.18.3.423","article-title":"Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death","volume":"18","author":"Kellner-Weibel","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0590","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0595","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0021-9150(96)05962-X","article-title":"Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein","volume":"127","author":"Syv\u00e4nne","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0600","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0021-9150(03)00247-8","article-title":"Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis","volume":"170","author":"Mikkola","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0605","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/01.ATV.17.11.2685","article-title":"HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum","volume":"17","author":"Fournier","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0610","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1172\/JCI118326","article-title":"Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and\/or human apolipoprotein AI","volume":"96","author":"Atger","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0615","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/140174301750164736","article-title":"Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes","volume":"35","author":"Pajunen","year":"2001","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0620","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-2275(20)32113-1","article-title":"Cell cholesterol efflux: integration of old and new observations provides new insights","volume":"40","author":"Rothblat","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0625","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1388-1981(99)00041-4","article-title":"Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP","volume":"1438","author":"Sakr","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0630","doi-asserted-by":"crossref","first-page":"30647","DOI":"10.1074\/jbc.271.48.30647","article-title":"Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors","volume":"271","author":"Smith","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0635","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"de la Llera-Moya","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0640","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1388-1981(01)00183-4","article-title":"Stably transfected ABCA1 antisense cell line has decreased ABCA1 mRNA and cAMP-induced cholesterol efflux to apolipoprotein AI and HDL","volume":"1534","author":"Zheng","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0645","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0167-4781(00)00133-0","article-title":"Identification of cAMP analogue inducible genes in RAW264 macrophages","volume":"1492","author":"Takahashi","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0650","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1074\/jbc.M110.116905","article-title":"cAMP\/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression","volume":"285","author":"Liao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0655","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/ATVBAHA.115.306268","article-title":"Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects","volume":"36","author":"Ronsein","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0660","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/01.ATV.0000148706.15947.8a","article-title":"Probucol inhibits ABCA1-mediated cellular lipid efflux","volume":"24","author":"Favari","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0665","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2362.2006.01673.x","article-title":"Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity","volume":"36","author":"Mweva","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0670","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1194\/jlr.M400133-JLR200","article-title":"SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome","volume":"45","author":"Yancey","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0675","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1194\/jlr.M500466-JLR200","article-title":"Measurement of cholesterol bidirectional flux between cells and lipoproteins","volume":"47","author":"Zimetti","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/ATVBAHA.113.302437","article-title":"Importance of evaluating cell cholesterol influx with efflux in determining the impact of human serum on cholesterol metabolism and atherosclerosis","volume":"34","author":"Weibel","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0685","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1194\/jlr.M008441","article-title":"Importance of macrophage cholesterol content on the flux of cholesterol mass","volume":"51","author":"Sankaranarayanan","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0690","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0695","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1194\/jlr.M500187-JLR200","article-title":"Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux","volume":"46","author":"Asztalos","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0700","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1021\/bi952242v","article-title":"Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins","volume":"35","author":"Zhao","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0705","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1194\/jlr.M031336","article-title":"Serum albumin acts as a shuttle to enhance cholesterol efflux from cells","volume":"54","author":"Sankaranarayanan","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0710","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1194\/jlr.M066613","article-title":"The effects of apolipoprotein B depletion on HDL subspecies composition and function","volume":"57","author":"Davidson","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0715","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-012-2570-9","article-title":"Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models","volume":"55","author":"Low","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0720","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0022-2275(20)31173-1","article-title":"Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids","volume":"42","author":"Nanjee","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0725","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1194\/jlr.D018051","article-title":"A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol","volume":"52","author":"Sankaranarayanan","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0730","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/ATVBAHA.117.309201","article-title":"Large-scale analysis of determinants, stability, and heritability of high-density lipoprotein cholesterol efflux capacity","volume":"37","author":"Koekemoer","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0735","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/j.1600-0854.2008.00801.x","article-title":"BODIPY-cholesterol: a new tool to visualize sterol trafficking in living cells and organisms","volume":"9","author":"H\u00f6ltt\u00e4-Vuori","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0740","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1021\/jo052029x","article-title":"First synthesis of free cholesterol\u2212BODIPY conjugates","volume":"71","author":"Li","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0745","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.bpj.2008.12.3922","article-title":"Membrane fluidity and lipid order in ternary giant unilamellar vesicles using a new bodipy-cholesterol derivative","volume":"96","author":"Ariola","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0750","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0755","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pcad.2015.05.004","article-title":"High-density lipoprotein function measurement in human studies: focus on cholesterol efflux capacity","volume":"58","author":"Rohatgi","year":"2015","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0760","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12944-017-0604-5","article-title":"High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis","volume":"16","author":"Qiu","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0765","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2015.09.013","article-title":"Cholesterol efflux capacity and pre-beta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapib","volume":"66","author":"Nicholls","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0770","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/eurheartj\/ehu105","article-title":"The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial","volume":"35","author":"Ray","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0775","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/ATVBAHA.117.310102","article-title":"Changes in high-density lipoprotein cholesterol efflux capacity after bariatric surgery are procedure dependent","volume":"38","author":"Heffron","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0780","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0785","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311978","article-title":"Trials and tribulations of CETP inhibitors","volume":"122","author":"Tall","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0790","doi-asserted-by":"crossref","DOI":"10.1161\/circ.132.suppl_3.17214","article-title":"Abstract 17214: differential relationships between serum cholesterol efflux capacities measured from three cell models and coronary artery disease status in the Montreal Heart Institute Biobank","volume":"132","author":"Rhainds","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0795","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004808","article-title":"Association of cholesterol efflux capacity with clinical features of metabolic syndrome: relevance to atherosclerosis","volume":"5","author":"Gall","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0800","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/ATVBAHA.115.306834","article-title":"Extended-release niacin\/laropiprant improves overall efficacy of postprandial reverse cholesterol transport","volume":"36","author":"El Khoury","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0805","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1194\/jlr.M054510","article-title":"Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART","volume":"56","author":"El Khoury","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0810","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/ATVBAHA.112.252841","article-title":"Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women","volume":"32","author":"Villard","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0815","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/ATVBAHA.112.300979","article-title":"Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels","volume":"33","author":"Villard","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0820","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbalip.2015.05.007","article-title":"Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A","volume":"1851","author":"Rached","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0825","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","article-title":"Cell-specific production, secretion, and function of apolipoprotein E","volume":"96","author":"Kockx","year":"2018","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0830","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1083\/jcb.97.4.1113","article-title":"Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes","volume":"97","author":"Werb","year":"1983","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0835","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92176","article-title":"Plasminogen promotes cholesterol efflux by the ABCA1 pathway","volume":"2","author":"Pamir","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0840","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1172\/JCI25327","article-title":"Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo","volume":"115","author":"Zhang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0845","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1194\/jlr.M075226","article-title":"A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans","volume":"58","author":"Cuchel","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0850","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI71610","article-title":"Lymphatic transport of high-density lipoproteins and chylomicrons","volume":"124","author":"Randolph","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0855","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0005-2760(82)90057-1","article-title":"Lipoproteins containing apolipoprotein A-I extracted from human aortas","volume":"711","author":"Heideman","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0860","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1042\/bst0120843","article-title":"High-density-lipoprotein (HDL) subfractions in interstitial fluid from human aortic intima and atherosclerotic lesions","volume":"12","author":"Smith","year":"1984","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0865","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.113.002624","article-title":"Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma","volume":"128","author":"Didonato","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0870","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nm.3459","article-title":"An abundant dysfunctional apolipoprotein A1 in human atheroma","volume":"20","author":"Huang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0875","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-511X-8-14","article-title":"Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography","volume":"8","author":"Linsel-Nitschke","year":"2009","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0880","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00522-6","article-title":"Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity","volume":"159","author":"von Eckardstein","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0885","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/ATVBAHA.108.179416","article-title":"Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway","volume":"29","author":"Catalano","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0890","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2012.12.024","article-title":"Endogenous CETP activity as a predictor of cardiovascular risk: determination of the optimal range","volume":"227","author":"Villard","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0895","doi-asserted-by":"crossref","first-page":"36596","DOI":"10.1074\/jbc.M006924200","article-title":"High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI","volume":"275","author":"Yancey","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0900","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case\u2013control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0905","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2015.06.028","article-title":"High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease","volume":"242","author":"Ishikawa","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0910","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1161\/ATVBAHA.115.305504","article-title":"High-density lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease","volume":"35","author":"Agarwala","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0915","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.jacc.2016.03.538","article-title":"Beyond coronary calcification, family history, and C-reactive protein: cholesterol efflux capacity and cardiovascular risk prediction","volume":"67","author":"Mody","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0920","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/CIRCULATIONAHA.116.025678","article-title":"Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)","volume":"135","author":"Khera","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0925","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1194\/jlr.P079525","article-title":"Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians","volume":"59","author":"Zimetti","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0930","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2016.10.054","article-title":"HDL cholesterol efflux capacity and cardiovascular events in patients with chronic kidney disease","volume":"69","author":"Bauer","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0935","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2017.12.031","article-title":"HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction","volume":"478","author":"Soares","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0940","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(15)60158-1","article-title":"Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"386","author":"Hovingh","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2018.08.002_bb0945","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/eurheartj\/ehv291","article-title":"Potent peroxisome proliferator-activated receptor-\u03b1 agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome","volume":"36","author":"Khera","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2018.08.002_bb0950","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.116.025687","article-title":"Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I, after acute myocardial Infarction: the AEGIS-I trial (ApoA-I Event Reducing in Ischemic Syndromes I)","volume":"134","author":"Michael Gibson","year":"2016","journal-title":"Circulation"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198118302014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198118302014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:01:54Z","timestamp":1761386514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198118302014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":190,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1388198118302014"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2018.08.002","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical appraisal of the measurement of serum \u2018cholesterol efflux capacity\u2019 and its use as surrogate marker of risk of cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}